For a 75‑kg woman who needs a total daily dose of 1500 mg glutathione, how should the tablets be administered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Glutathione Tablet Dosing for 75 kg Woman Requiring 1500 mg Daily

For a 75 kg woman needing 1500 mg glutathione daily, divide the dose into two administrations: take 750 mg twice daily with meals (morning and evening) to optimize absorption and minimize gastrointestinal side effects.

Practical Dosing Strategy

Based on available evidence, here's how to structure the regimen:

Dose Division

  • Total daily dose: 1500 mg
  • Recommended schedule: 750 mg twice daily
  • Timing: With breakfast and dinner

Rationale for Split Dosing

The evidence from clinical trials suggests that divided dosing improves tolerability and may enhance systemic availability 1, 2. While single daily dosing has been studied at lower doses (250-1000 mg/day), the 1500 mg target dose warrants splitting to:

  • Reduce potential gastrointestinal discomfort
  • Maintain more consistent blood levels throughout the day
  • Improve overall absorption efficiency

Administration Guidelines

Take with food: Studies demonstrate that glutathione absorption and tolerability improve when taken with meals 1, 3. This mirrors the approach used with other medications where gastrointestinal side effects are a concern.

Formulation considerations:

  • If using standard tablets (typically 250 mg each): Take 3 tablets twice daily
  • If using 500 mg tablets: Take 1.5 tablets twice daily (or 2 tablets morning, 1 tablet evening to total 1500 mg)
  • Orally dissolving films show superior pharmacokinetics compared to tablets, with higher plasma concentrations at 4-6 hours post-dose 4

Expected Timeline and Monitoring

Research indicates glutathione levels increase progressively:

  • Week 1: Initial elevation in blood glutathione (17-30% increase) 1
  • Week 2: Peak increases observed (up to 40% in whole blood, 100% in immune cells) 2
  • Month 1-6: Sustained elevation with continued supplementation 1

Important Caveats

Bioavailability limitations: Standard oral glutathione has poor gastrointestinal absorption 5, 6. The high 1500 mg dose compensates for this limitation, though liposomal or sublingual formulations may offer superior systemic delivery 2, 5.

Individual variation: Response varies significantly between individuals. Some studies show melanin index reduction in sun-exposed areas with 500 mg/day, while others require higher doses 3, 7.

Safety profile: At doses up to 1000 mg/day for 6 months, glutathione supplementation shows good safety with minimal adverse events 1. The 1500 mg dose exceeds most studied protocols but follows the principle that higher doses compensate for limited oral bioavailability 3, 7.

Alternative Considerations

If standard tablets prove ineffective or poorly tolerated:

  • Liposomal formulations: Show 40% increase in whole blood levels and 100% increase in immune cells at 500-1000 mg/day 2
  • Sublingual/orobuccal films: Bypass first-pass metabolism, achieving higher systemic levels 5, 4
  • Consider reducing to 1000 mg/day (500 mg twice daily) if gastrointestinal symptoms develop, as this dose shows clinical efficacy in trials 1, 3

Do not use intravenous glutathione outside supervised medical settings due to serious safety concerns including anaphylaxis and hepatotoxicity 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.